190 related articles for article (PubMed ID: 29634381)
1. Efficacy of HL036 versus Cyclosporine A in the Treatment of Naturally Occurring Canine Keratoconjunctivitis Sicca.
Lee HB; Choi HJ; Cho SM; Kang S; Ahn HK; Song YJ; Kim YJ; Son WC
Curr Eye Res; 2018 Jul; 43(7):889-895. PubMed ID: 29634381
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
Moore CP; McHugh JB; Thorne JG; Phillips TE
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
[TBL] [Abstract][Full Text] [Related]
3. Clinical and light microscopic studies of the conjunctival tissues of dogs with bilateral keratoconjunctivitis sicca before and after treatment with topical 2% cyclosporine.
Izci C; Celik I; Alkan F; Erol M; Sur E
Biotech Histochem; 2015 Apr; 90(3):223-30. PubMed ID: 25747049
[TBL] [Abstract][Full Text] [Related]
4. The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy.
Gao J; Schwalb TA; Addeo JV; Ghosn CR; Stern ME
Cornea; 1998 Nov; 17(6):654-63. PubMed ID: 9820947
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 1% cyclosporine eye drops in olive oil and in linseed oil to treat experimentally-induced keratoconjunctivitis sicca in rabbits.
Parrilha LR; Nai GA; Giuffrida R; Barbero RC; Padovani LD; Pereira RH; Silva DA; Silva MC; Diniz MS; Andrade SF
Arq Bras Oftalmol; 2015; 78(5):295-9. PubMed ID: 26466228
[TBL] [Abstract][Full Text] [Related]
6. Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study.
Barachetti L; Rampazzo A; Mortellaro CM; Scevola S; Gilger BC
Vet Ophthalmol; 2015 May; 18(3):234-41. PubMed ID: 24799029
[TBL] [Abstract][Full Text] [Related]
7. Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
Strong B; Farley W; Stern ME; Pflugfelder SC
Cornea; 2005 Jan; 24(1):80-5. PubMed ID: 15604871
[TBL] [Abstract][Full Text] [Related]
8. Assessment of corneal and conjunctival metaplasia by impression cytology during the treatment of canine keratoconjunctivitis sicca.
Radziejewski K; Balicki I; Szadkowski M
Acta Vet Hung; 2018 Jun; 66(2):189-203. PubMed ID: 29958527
[TBL] [Abstract][Full Text] [Related]
9. Histologic characteristics and local cellular immunity of the gland of the third eyelid after topical ophthalmic administration of 2% cyclosporine for treatment of dogs with keratoconjunctivitis sicca.
Izci C; Celik I; Alkan F; Ogurtan Z; Ceylan C; Sur E; Ozkan Y
Am J Vet Res; 2002 May; 63(5):688-94. PubMed ID: 12013470
[TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of pimecrolimus eye drops for treatment of canine keratoconjunctivitis sicca: a comparison with cyclosporine A.
Ofri R; Lambrou GN; Allgoewer I; Graenitz U; Pena TM; Spiess BM; Latour E
Vet J; 2009 Jan; 179(1):70-7. PubMed ID: 17950639
[TBL] [Abstract][Full Text] [Related]
11. Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca.
Radziejewski K; Balicki I
Acta Vet Hung; 2016 Sep; 64(3):313-329. PubMed ID: 27653428
[TBL] [Abstract][Full Text] [Related]
12. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
Berdoulay A; English RV; Nadelstein B
Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of 1% cyclosporine for topical treatment of keratoconjunctivitis sicca in dogs.
Olivero DK; Davidson MG; English RV; Nasisse MP; Jamieson VE; Gerig TM
J Am Vet Med Assoc; 1991 Oct; 199(8):1039-42. PubMed ID: 1748606
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
Kaswan RL; Salisbury MA; Ward DA
Arch Ophthalmol; 1989 Aug; 107(8):1210-6. PubMed ID: 2757551
[TBL] [Abstract][Full Text] [Related]
15. [Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca].
Schrell C; Cursiefen C; Kruse F; Jacobi C
Klin Monbl Augenheilkd; 2012 May; 229(5):548-53. PubMed ID: 22189827
[TBL] [Abstract][Full Text] [Related]
16. A topical aqueous calcineurin inhibitor for the treatment of naturally occurring keratoconjunctivitis sicca in dogs.
Gilger BC; Wilkie DA; Salmon JH; Peel MR
Vet Ophthalmol; 2013 May; 16(3):192-7. PubMed ID: 22853450
[TBL] [Abstract][Full Text] [Related]
17. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of soft contact lenses in severe keratoconjunctivitis sicca treated with local immunosuppressive therapy].
Safonova TN; Gladkova OV; Boev VI; Fedorov AA
Vestn Oftalmol; 2016; 132(5):39-48. PubMed ID: 27911424
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of ocular surface TNF-α reduces ocular surface and lacrimal gland inflammation induced by in vivo dry eye.
Ji YW; Byun YJ; Choi W; Jeong E; Kim JS; Noh H; Kim ES; Song YJ; Park SK; Lee HK
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7557-66. PubMed ID: 24052636
[TBL] [Abstract][Full Text] [Related]
20. Tear protein profiles vs. clinical characteristics of untreated and cyclosporine-treated canine KCS.
Fullard RJ; Kaswan RM; Bounous DI; Hirsh SG
J Am Optom Assoc; 1995 Jul; 66(7):397-404. PubMed ID: 7560726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
